American Society of Hematology

American Society of Hematology Announces 2019 Scholar Award Recipients

Published on: November 28, 2018

(WASHINGTON, November 28, 2018) – The American Society of Hematology (ASH) today announced the recipients of its 2019 Scholar Awards. One of ASH’s most prestigious award programs, the ASH Scholar Awards financially support fellows and junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators. 

Each Scholar Award provides $100,000 for fellows or $150,000 for junior faculty over a two- to three-year period. The program funds hematologists in the United States and Canada who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders. ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH recognizes this year’s corporate supporters, AstraZeneca, Janssen Biotech, Inc., and Pharmacyclics LLC.

“For over 30 years, ASH has launched successful independent research careers in hematology by giving promising scholars the freedom to pursue important scientific questions,” said ASH President Alexis A. Thompson, MD, MPH, of the Ann and Robert H. Lurie Children’s Hospital of Chicago. “The Scholar Award recipients announced today were chosen because ASH has confidence that their research is critical to hematology. They join an impressive community of former ASH Scholar Awards recipients who have gone on to publish thousands of papers, hold patents, and receive more than $1 billion in grants from various funding institutions.”

The 2019 Scholar Awards recipients are:

Basic/Translational Fellow

Tessa Barrett, PhD New York University School of Medicine
New York, NY
Sheng Cai, MD, PhD Memorial Sloan Kettering Cancer Center
New York, NY
M. Ryan Corces, PhD Stanford University
Stanford, CA
Nirav Dhanesha, PhD University of Iowa
Iowa City, Iowa
Benjamin Durham, MD Memorial Sloan Kettering Cancer Center
New York, NY
Craig Forester, MD, PhD University of California, San Francisco
San Francisco, CA
Christian Hurtz, PhD University of Pennsylvania
Philadelphia, PA
Victoria Mascetti, PhD Stanford University
Stanford, CA
Sol Schulman, MD, PhD Beth Israel Deaconess Medical Center
Boston, MA
Elisa ten Hacken, PhD Dana-Farber Cancer Institute
Boston, MA
Ze Zheng, PhD Columbia University
New York, NY

 
Basic/Translational Junior Faculty

Joseph Aslan, PhD Oregon Health & Science University
Portland, OR
Sergei Doulatov, PhD University of Washington
Seattle, WA
Ann-Kathrin Eisfeld, MD The Ohio State University
Columbus, OH
Jonathan Hoggatt, PhD Massachusetts General Hospital
Boston, MA
Meixiao Long, MD, PhD The Ohio State University
Columbus, OH
Silvia Marino, PhD Indiana University
Bloomington, IN
Julia Maxson, PhD Oregon Health & Science University
Portland, OR
Ryan Morin, PhD Simon Fraser University
Burnaby, BC, Canada
Esther Obeng, MD, PhD St. Jude Children's Research Hospital
Memphis, TN
Russell Ryan, MD University of Michigan
Ann Arbor, MI
Sarah Sartain, MD Baylor College of Medicine
Houston, TX
Ji Zhang, PhD Indiana University
Bloomington, IN

 
Clinical Fellow

Pavan Bachireddy, MD Dana-Farber Cancer Institute
Boston, MA
Kelly Bolton, MD, PhD Memorial Sloan Kettering Cancer Center
New York, NY

 
Clinical Junior Faculty

Inhye Ahn, MD National Institutes of Health
Bethesda, MD
Nicholas Short, MD The University of Texas MD Anderson Cancer Center
Houston, TX
Moritz Stolla, MD Bloodworks Northwest
Seattle, WA
Anthony Sung, MD Duke University
Durham, NC

 
Joanne Levy, MD, Memorial Award for Outstanding Achievement

Marco Ruella, MD, of University of Pennsylvania, will receive the 2018 Joanne Levy, MD, Memorial Award for Outstanding Achievement. This award is made possible by the family of past ASH Scholar Award recipient and distinguished Society member Joanne Levy, MD, who passed away in 2004. It is presented to the current ASH Scholar with the highest-scoring abstract for the ASH Annual Meeting, as determined by the appointed abstract reviewers.

Dr. Ruella is being honored for his oral abstract (698), “CAR T Cell Cytotoxicity Is Dependent on Death Receptor-Driven Apoptosis.”


The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.

Contact:
Sara Khalaf, American Society of Hematology
skhalaf@hematology.org; 202-552-4925

back to top